InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Kumar Ramesh, Director. Officer active across 1 companies, notably Ocugen, Inc.. In total, 7 filings have been logged. The latest transaction was filed on 18 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations7 total
€3,5487,500 shares@ €0.4730.0008% mcap15.2% of flow
Common Stock
SEC:0001062993-22-010494:0·
€3,3527,500 shares@ €0.4470.0008% mcap14.4% of flow
Common Stock
SEC:0001062993-22-001294:0·
€3,3527,500 shares@ €0.4470.0008% mcap33.9% of flow
Common Stock
SEC:0001062993-22-001294·
€3,2937,500 shares@ €0.43910.0008% mcap33.3% of flow
Common Stock
SEC:0001879785-21-000009·
€3,2937,500 shares@ €0.43910.0008% mcap14.1% of flow
Common Stock
SEC:0001879785-21-000009:0·
€3,2437,500 shares@ €0.43240.0008% mcap32.8% of flow
Common Stock
SEC:0001192482-21-000636·
€3,2437,500 shares@ €0.43240.0008% mcap13.9% of flow
Common Stock
SEC:0001192482-21-000636:0·
7 of 7 declarations
About Kumar Ramesh
Kumar Ramesh is a Board Member at Ocugen, Inc., a company focused on developing gene therapies and treatments for eye diseases. With expertise in the biopharmaceutical sector, he contributes to the strategic direction of the company. His role involves overseeing operations and making key decisions for the organization's growth.
